Sex Differences in Renal Sodium Handling
Sex Differences in Renal Sodium Handling
批准号:
10488251
负责人:
Eman Gohar
金额:
$24.69万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-09-13 至 2024-08-31
关键词:
ATP ReceptorsAgeAmerican Heart AssociationAnabolismAreaAttenuatedBioinformaticsBiologicalBlood PressureCalciumCardiovascular systemDataDefectDevelopmentDiseaseDoctor of PhilosophyDuct (organ) structureDuctal Epithelial CellEndothelinEndothelin A ReceptorEndothelin-1EstradiolEstrogen ReceptorsEstrogensExcretory functionFemaleFunctional disorderFundingGPER geneGene ExpressionGoalsGrantHomeostasisHypertensionImageKidneyKidney DiseasesKnowledgeMaintenanceMediatingMenopauseMentorsMentorshipMissionNatriuresisNatriuretic FactorsOperative Surgical ProceduresPathway interactionsPhasePhospholipase CPhysiologyPlayPostmenopausePremenopauseProductionPublishingPurinoceptorRattusReceptor ActivationReceptor InhibitionReceptor SignalingRegulationResearchResearch PersonnelRiskRoleSex DifferencesSignal PathwaySignal TransductionSodiumSodium ChlorideSystemTechnical ExpertiseTestingTrainingTranslational ResearchUnited States National Institutes of HealthWomanWritingblood pressure controlblood pressure regulationcareercareer developmentdesignepithelial Na+ channelestrogen receptor gammaexperimental studyfemale sex hormonekidney medullamalemennovelprogramsreceptorreceptor expressionresponsesalt intakesalureticsexskillstherapeutic targettranscriptome sequencingurinary
中文摘要
摘要
Eman Y.Gohar博士的K99/R00应用程序旨在获取知识和培训
有必要转变为一名独立资助的调查员,领导着眼于性的研究项目
心血管和肾脏生理学的差异。高血压和肾脏相关疾病更多
在男性和绝经后女性中常见,与绝经前女性相比。肾嘌呤能信号转导
已成为控制血压和钠动态平衡的重要系统。我们有一个最新的
雌二醇刺激钠排泄和增加肾脏嘌呤能受体表达的证据
(P2Y2和4-R)。重要的是,在非肾脏组织中已经证实了嘌呤能系统的性别差异,
然而,肾脏嘌呤能信号的性别差异尚不清楚。新的雌激素受体G
蛋白偶联雌激素受体(GPER)在肾髓质中表达。GPER激活引发
对盐引起的并发症的心血管和肾脏保护作用。然而,它在Na中的作用
尚未定义处理。我们的初步数据表明,肾髓质中GPER的激活促进了
雌性大鼠通过内皮素-1(ET-1)依赖机制排泄NA。在目前的提案中,
总体假设是,女性肾脏钠转运的增强至少部分是由于ATP/P2Y2和4-R/
肾髓质内的磷脂酶C/上皮钠通道(ENaC)和E2/GPER/ET-1/ENaC信号通路。
这一假设将通过两个具体目标进行检验。其中一个目标是测试雌性老鼠是否增强了
肾髓质中的P2Y2&4-R信号与男性相比,对高盐摄入的反应。第二个目标是
确定局部合成的E2是否激活肾髓质GPER以促进ET-1依赖
抑制ENaC对雌性大鼠的利钠作用。在大卫·波洛克博士和共同导师的指导下,
Gohar博士扩展了她目前对嘌呤能信号和快速雌激素信号的研究
并提出了涉及三个主要目标的额外培训:i)技术开发;Gohar博士将
发展钙成像、RNA测序和
生物信息学,除了磨练她的外科技能,ii)实验室管理方面的职业发展,
指导和资助写作,iii)翻译研究培训。这一五年计划将使戈哈尔博士为
R01提交,并让她走上了一条成功的独立职业生涯之路。
英文摘要
SUMMARY
This K99/R00 application from Eman Y. Gohar, PhD, is designed to acquire the knowledge and training
necessary to transition into an independently-funded investigator leading a research program focused on sex
differences in cardiovascular and renal physiology. Hypertension and kidney-related diseases are more
common in men and postmenopausal women compared to premenopausal women. Renal purinergic signaling
has emerged as an important system in the control of blood pressure and Na+ homeostasis. We have a recent
evidence that estradiol (E2) stimulates Na+ excretion and increases the expression of renal purinergic receptors
(P2Y2&4-R). Importantly, sex differences in the purinergic system has been demonstrated in non-renal tissues,
however sex-related differences in renal purinergic signaling are not clear. The novel estrogen receptor, G
protein-coupled estrogen receptor (GPER), is expressed in the renal medulla. GPER activation elicits
cardiovascular and nephroprotective effects against salt-induced complications. However, its role in Na+
handling is not yet defined. Our preliminary data indicate that activation of GPER in the renal medulla promotes
Na+ excretion via an endothelin-1 (ET-1)-dependent mechanism in female rats. In the current proposal, the
overall hypothesis is that the enhanced renal Na+ handling in females is due, at least in part, to ATP/P2Y2&4-R/
phospholipase C/ epithelial Na+ channels (ENaC) and E2/GPER/ET-1/ENaC signaling within the renal medulla.
This hypothesis will be tested by two specific aims. One aim will test whether female rats have enhanced
P2Y2&4-R signaling in the renal medulla compared to males in response to high salt intake. The second aim will
determine whether locally synthetized E2 activates GPER in the renal medulla to promote ET-1-dependent
natriuresis in female rats via inhibition of ENaC. Under the mentorship of Dr. David Pollock and co-mentor, Dr.
Edward Inscho, Dr. Gohar extends her current research on purinergic signaling and rapid estrogen signaling
and proposes additional training that involves three major goals: i) technical development; Dr. Gohar will
develop knowledge and technical expertise in the fields of calcium imaging, RNA sequencing and
bioinformatics, beside refining her surgical skills, ii) professional career development in lab management,
mentoring and grant writing, iii) training in translational research. This 5-year plan will prepare Dr. Gohar for an
R01 submission and set her on a path for a successful independent career.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Sex Differences in Renal Sodium Handling
-
批准号:10469099
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2021
-
负责人:Eman Gohar
-
依托单位:
Sex Differences in Renal Sodium Handling
-
批准号:10683265
-
项目类别:
-
资助金额:$24.39万
-
财政年份:2021
-
负责人:Eman Gohar
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: